PetMed Express Future Growth

Future criteria checks 3/6

PetMed Express is forecast to grow earnings and revenue by 109.1% and 7.1% per annum respectively. EPS is expected to grow by 107.4% per annum. Return on equity is forecast to be 2.3% in 3 years.

Key information

109.1%

Earnings growth rate

107.4%

EPS growth rate

Specialty Retail earnings growth	12.3%
Revenue growth rate	7.1%
Future return on equity	2.3%
Analyst coverage	Low
Last updated	15 Apr 2024

Recent future growth updates

Recent updates

PetMed Express CFO to leave post today, by remain with company over transition period

Aug 02

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

Jul 29

PetMed Express FQ1 2023 Earnings Preview

Jul 24

PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform

Jul 15

Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture

Jul 04

PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth

May 26

PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30

May 13

Silver Ring Value Partners - PetMed Express: Squeezed Out Of Obtaining New Customers

Feb 22

PetMed Express: Avoid For Now

Jan 17

PetMed Express Needs A White Knight

Sep 26

PetMed Express (NASDAQ:PETS) Is Increasing Its Dividend To US$0.30

Jul 29

PetMed Express: Top Dog For Pet Dividends - Pet Industry Review

Jul 11

PetMed Express: A Safe Dividend, But Lacks A Margin Of Safety

Jun 15

Estimating The Intrinsic Value Of PetMed Express, Inc. (NASDAQ:PETS)

Jun 11

PetMed reaches highest level since January as meme stocks rally

Jun 02

Earnings and Revenue Growth Forecasts

NasdaqGS:PETS - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2026	325	3	N/A	N/A	1
3/31/2025	300	0	N/A	N/A	2
3/31/2024	280	-4	N/A	N/A	1
12/31/2023	277	-3	2	7	N/A
9/30/2023	271	-6	17	22	N/A
6/30/2023	265	-3	17	22	N/A
3/31/2023	257	5	23	28	N/A
12/31/2022	259	9	23	27	N/A
9/30/2022	262	16	19	23	N/A
6/30/2022	264	19	23	25	N/A
3/31/2022	272	19	17	18	N/A
12/31/2021	279	22	26	28	N/A
9/30/2021	284	25	24	26	N/A
6/30/2021	292	27	48	51	N/A
3/31/2021	304	24	38	40	N/A
12/31/2020	312	31	37	39	N/A
9/30/2020	306	30	34	37	N/A
6/30/2020	300	28	25	28	N/A
3/31/2020	284	26	37	39	N/A
12/31/2019	274	25	33	35	N/A
9/30/2019	275	26	41	42	N/A
6/30/2019	276	31	23	23	N/A
3/31/2019	283	38	45	45	N/A
12/31/2018	286	41	34	34	N/A
9/30/2018	286	43	39	39	N/A
6/30/2018	282	41	45	46	N/A
3/31/2018	274	37	37	37	N/A
12/31/2017	270	35	49	51	N/A
9/30/2017	262	30	N/A	38	N/A
6/30/2017	256	27	N/A	48	N/A
3/31/2017	249	24	N/A	47	N/A
12/31/2016	242	22	N/A	30	N/A
9/30/2016	240	22	N/A	35	N/A
6/30/2016	236	21	N/A	23	N/A
3/31/2016	235	21	N/A	21	N/A
12/31/2015	229	20	N/A	25	N/A
9/30/2015	228	20	N/A	22	N/A
6/30/2015	228	18	N/A	29	N/A
3/31/2015	229	17	N/A	32	N/A
12/31/2014	228	17	N/A	25	N/A
9/30/2014	229	17	N/A	13	N/A
6/30/2014	232	18	N/A	8	N/A
3/31/2014	233	18	N/A	14	N/A
12/31/2013	236	18	N/A	9	N/A
9/30/2013	235	18	N/A	22	N/A
6/30/2013	233	18	N/A	19	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PETS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).

Earnings vs Market: PETS is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: PETS is expected to become profitable in the next 3 years.

Revenue vs Market: PETS's revenue (7.1% per year) is forecast to grow slower than the US market (8.3% per year).

High Growth Revenue: PETS's revenue (7.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PETS's Return on Equity is forecast to be low in 3 years time (2.3%).

PetMed Express Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Price target decreased by 21% to US$7.75

Price target decreased by 18% to US$15.00

Consensus EPS estimates fall by 31%, revenue upgraded

Consensus EPS estimates fall by 20%

Consensus EPS estimates fall by 48%

Price target decreased to US$20.67

Recent updates

Price target decreased by 21% to US$7.75

PetMed Express, Inc. Announces Executive Changes

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. to Report Q3, 2024 Results on Feb 08, 2024

PetMed Express, Inc. Announces Management Changes

Independent Chairman of the Board recently bought US$301k worth of stock

CEO, President & Director recently bought US$101k worth of stock

PetMed Express, Inc. Makes Decision to Suspend the Quarterly Dividend Effective the Quarter Ended September 30, 2023

PetMed Express, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Price target decreased by 18% to US$15.00

Now 21% undervalued after recent price drop

A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)

PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 9.0% yield

First quarter 2024 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Now 21% undervalued after recent price drop

High number of new directors

Consensus EPS estimates fall by 31%, revenue upgraded

Upcoming dividend of US$0.30 per share at 8.1% yield

Full year 2023 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. Declares a Quarterly Dividend, Payable on June 12, 2023

PetMed Express, Inc., Annual General Meeting, Aug 03, 2023

Now 22% undervalued after recent price drop

PetMed Express, Inc. Appoints Sandra Y. Campos to its Board of Directors

PetMed Express, Inc. to Report Q4, 2023 Results on May 22, 2023

Consensus EPS estimates fall by 20%

The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence

Consensus EPS estimates fall by 48%

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Third quarter 2023 earnings released: US$0.001 loss per share (vs US$0.21 profit in 3Q 2022)

PetMed Express, Inc. Declares Quarterly Dividend, Payable on February 27, 2023

Investor sentiment improves as stock rises 16%

PetMed Express, Inc. to Report Q3, 2023 Results on Feb 06, 2023

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Price target decreased to US$20.67

PetMed Express, Inc. Declares Quarterly Dividend, Payable on November 30, 2022

Price target decreased to US$21.33

PetMed Express, Inc. to Report Q2, 2023 Results on Nov 07, 2022

PetMed Express Puts Are Compelling

Now 21% undervalued after recent price drop

Upcoming dividend of US$0.30 per share

Now 23% undervalued after recent price drop

PetMed Express CFO to leave post today, by remain with company over transition period

Consensus EPS estimates fall by 15%

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Petmed Express, Inc. Declares Quarterly Dividend, Payable on August 19, 2022

PetMed Express FQ1 2023 Earnings Preview

PetMed Express, Inc. Announces Executive Changes

PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform

PetMed Express, Inc. to Report Q1, 2023 Results on Jul 25, 2022

Price target decreased to US$23.33

Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture

PetMed Express, Inc., Annual General Meeting, Jul 28, 2022

PetMed Express, Inc., Annual General Meeting, Jul 28, 2022

PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth

PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

PetMed Express, Inc. Declares Quarterly Dividend, Payable on May 27, 2022

PetMed Express, Inc. to Report Q4, 2022 Results on May 09, 2022

Price target decreased to US$25.67

PetMed Express, Inc. Appoints Diana Garvis Purcel to Board of Directors, Effective April 4, 2022

Silver Ring Value Partners - PetMed Express: Squeezed Out Of Obtaining New Customers

Consensus EPS estimates fall by 15%